MARKET

ITCI

ITCI

INTRA CELLULAR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.60
-0.21
-0.88%
Opening 14:33 01/29 EST
OPEN
23.87
PREV CLOSE
23.81
HIGH
23.92
LOW
23.15
VOLUME
429.97K
TURNOVER
--
52 WEEK HIGH
43.56
52 WEEK LOW
6.75
MARKET CAP
1.54B
P/E (TTM)
-8.7837
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ITCI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ITCI News

  • Intra-Cellular Therapies (NASDAQ:ITCI) Shareholders Booked A 99% Gain In The Last Year
  • Simply Wall St..2d ago
  • ClearBridge Small Cap Value Strategy Portfolio Manager Commentary Q4 2019
  • Seeking Alpha - Article.5d ago
  • Implied Volatility Surging for Intra-Cellular (ITCI) Stock Options
  • Zacks.01/21 13:50
  • Top Ranked Momentum Stocks to Buy for January 10th
  • Zacks.01/10 14:04

More

Industry

Biotechnology & Medical Research
-0.03%
Pharmaceuticals & Medical Research
+0.38%

Hot Stocks

Name
Price
%Change

About ITCI

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company is discovering and developing drugs for the treatment of neurological and psychiatric disorders. Lumateperone (also known as ITI-007) is its lead product candidate. The Company's bipolar depression program consists of two Phase III multi-center, randomized, double-blind, placebo-controlled clinical trials: one to evaluate lumateperone as a monotherapy and the other to evaluate lumateperone as an adjunctive therapy with lithium or valproate. The Company initiated Phase III development of lumateperone for the treatment of agitation in patients with dementia, including Alzheimer's Disease (AD).
More

Webull offers Intra-Cellular Therapies Inc (ITCI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.